Orange Book product · Brand (NDA)
XEGLYZE
ABAMETAPIR
Brand (NDA)NDA 206966DISCN LNHC
At a glance
Jul 24, 2020
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 24, 2020
6 yr ago
Today
Patent 7812163 expires
Listed drug product patent expiration.
Oct 28, 2026
in 4 mo
Patent 10292389 expires
Listed drug product patent expiration.
Dec 17, 2034
in 8 yr 7 mo
Pharmaceutical detail
Active ingredient
ABAMETAPIR
Strength
0.74%
Dosage form
LOTION
Route
TOPICAL
TE code
Not listed
Application
NDA 206966
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7812163 | Oct 28, 2026 | in 4 mo | ProductU-2863 |
| 10292389 | Dec 17, 2034 | in 8 yr 7 mo | ProductU-2863 |
